The Arbitration Panel Issued A Final Award Which Found And Concluded That Aadi Bioscience Did Not Breach The EOC Pharma License Agreement And Accordingly Is Not Liable For Any Damages To EOC - Filing
The Arbitration Panel Issued A Final Award Which Found And Concluded That Aadi Bioscience Did Not Breach The EOC Pharma License Agreement And Accordingly Is Not Liable For Any Damages To EOC - Filing
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.